Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 125Myelodysplastic Syndromes 120Precursor Cell Lymphoblastic Leukemia-Lymphoma 107Leukemia 86Hodgkin Disease 81Leukemia, Lymphocytic, Chronic, B-Cell 78Lymphoma 76Multiple Myeloma 75Lymphoma, Non-Hodgkin 75Myeloproliferative Disorders 57Graft vs Host Disease 55Lymphoma, Follicular 54Lymphoma, Mantle-Cell 50Lymphoma, Large B-Cell, Diffuse 50Leukemia, Myeloid, Accelerated Phase 50Leukemia, Myelomonocytic, Chronic 48Congenital Abnormalities 48Leukemia, Myelogenous, Chronic, BCR-ABL Positive 47Hematologic Neoplasms 45Lymphoma, B-Cell, Marginal Zone 44Leukemia, Myeloid, Chronic-Phase 44Burkitt Lymphoma 42Primary Myelofibrosis 41Blast Crisis 39Neoplasms, Plasma Cell 38Lymphoma, Large-Cell, Immunoblastic 34Waldenstrom Macroglobulinemia 26Myelodysplastic-Myeloproliferative Diseases 25Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Anemia, Refractory, with Excess of Blasts 24

Interventions

Manual Lymphatic Drainage 11Exercise 11Low-Level Light Therapy 6Standard of Care 4Radiotherapy 4Physical Therapy Modalities 4Exercise Therapy 4Acupuncture Therapy 4Surveys and Questionnaires 3Resistance Training 3Methods 3Lipectomy 3Indocyanine Green 3Compression Bandages 3pycnogenols 2Yoga 2Technetium Tc 99m Sulfur Colloid 2Restraint, Physical 2Pentoxifylline 2Lymph Node Excision 2Ketoprofen 2High-Energy Shock Waves 2Early Intervention, Educational 2Control Groups 2Bupivacaine 2Bevacizumab 2specific substance maruyama 1pirfenidone 1pazopanib 1carbohydrate-deficient transferrin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphedema × Tacrolimus × Clear all
NCT06306274 2024-12-02

Topical Tacrolimus for Breast Cancer-related Lymphedema

Odense University Hospital

Phase 2/3 Enrolling by invitation
80 enrolled

Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡